CStone Pharmaceuticals Share Price OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
09:40:26 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.7547 USD | +11.10% |
|
+0.00% | -15.49% |
| 09/10 | GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target | MT |
| 24/09 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| Market Cap | 691.47Cr 103.23Cr 92Cr 86Cr 78Cr 147.3Cr 9.99TCr 147.93Cr 1.03TCr 404.46Cr 5.09TCr 387.67Cr 379.19Cr 16TCr | P/E 2026 * |
-15x | P/E 2027 * | 4.06x |
|---|---|---|---|---|---|
| Enterprise Value | 593.7Cr 89Cr 79Cr 74Cr 67Cr 126.47Cr 8.58TCr 127.02Cr 886.31Cr 347.27Cr 4.37TCr 332.85Cr 325.58Cr 14TCr | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 1.68x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +11.10% | ||
| 1 week | +0.00% | ||
| Current month | +0.00% | ||
| 1 month | -17.15% | ||
| 3 months | +6.30% | ||
| 6 months | -25.28% | ||
| Current year | -15.49% |
| 1 month | 0.66 |  | 0.75 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 1.58 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.10% | +0.00% | - | - | 103.23Cr | |
| +0.83% | +3.19% | +41.49% | +103.56% | 1,05100Cr | |
| +1.93% | +2.11% | +37.08% | +65.09% | 63TCr | |
| +1.49% | +5.19% | +19.94% | +85.69% | 49TCr | |
| +2.26% | +0.90% | +69.32% | +40.53% | 36TCr | |
| +1.45% | +3.50% | +23.29% | +41.62% | 34TCr | |
| +1.17% | +2.37% | +13.47% | +33.64% | 27TCr | |
| +0.89% | +1.08% | -6.13% | +9.29% | 25TCr | |
| +1.82% | +2.94% | +42.99% | +52.95% | 22TCr | |
| +2.77% | +4.44% | +29.01% | +98.99% | 19TCr | |
| Average | +2.57% | +2.53% | +30.05% | +59.04% | 42.26TCr | |
| Weighted average by Cap. | +1.47% | +2.44% | +33.36% | +69.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42Cr 6.32Cr 5.64Cr 5.25Cr 4.77Cr 9.01Cr 611.41Cr 9.05Cr 63Cr 25Cr 311.72Cr 24Cr 23Cr 1TCr | 172.22Cr 26Cr 23Cr 21Cr 19Cr 37Cr 2.49TCr 37Cr 257.1Cr 100.74Cr 1.27TCr 97Cr 94Cr 4.07TCr |
| Net income | -38Cr -5.73Cr -5.11Cr -4.76Cr -4.33Cr -8.17Cr -554.18Cr -8.21Cr -57Cr -22Cr -282.54Cr -22Cr -21Cr -906.69Cr | 68Cr 10Cr 9.07Cr 8.44Cr 7.68Cr 14Cr 983.19Cr 15Cr 101.58Cr 40Cr 501.26Cr 38Cr 37Cr 1.61TCr |
| Net Debt | -98Cr -15Cr -13Cr -12Cr -11Cr -21Cr -1.41TCr -21Cr -145.95Cr -57Cr -720.22Cr -55Cr -54Cr -2.31TCr | -402.28Cr -60Cr -54Cr -50Cr -45Cr -86Cr -5.81TCr -86Cr -600.54Cr -235.3Cr -2.96TCr -225.53Cr -220.6Cr -9.51TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $0.000000 | - | 50 |
| 05/26/05 | $0.000000 | -100.00% | 16,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
